Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo
Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
To study the correlation between the content of natural IgM in patients' blood samples and
liposomal doxorubicin for clinical use, and to explore the possibility of using natural IgM
content to guide clinical accurate medication.